Bank of America just raised its EUR/USD forecast
Cardlytics, Inc. (NASDAQ:CDLX) Chief Executive Officer Amit Gupta sold a total of 136,945 shares of common stock on August 18 and 19, 2025, for approximately $153,582. The sales were executed in multiple transactions with prices ranging from $1.118 to $1.125. The transaction comes as the company’s stock has declined over 70% year-to-date, according to InvestingPro data, with shares trading near their 52-week low of $1.03.
The sales were to cover tax obligations resulting from the vesting of restricted stock units.
On August 18, Gupta also exercised options to acquire 250,000 shares of Cardlytics common stock, which had a value of $0.
Following these transactions, Gupta directly owns 491,759 shares of Cardlytics, Inc. For deeper insights into Cardlytics’ financial health, valuation metrics, and expert analysis, subscribers can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks.
In other recent news, Cardlytics Inc . reported its second-quarter 2025 earnings, revealing an earnings per share (EPS) of -$0.13, surpassing analyst expectations of -$0.39. However, the company faced a revenue shortfall, reporting $63.2 million compared to the forecasted $64.06 million. This mixed performance highlights the tension between exceeding EPS expectations and missing revenue targets. Despite the positive EPS surprise, investors expressed concerns over the declining revenue figures. Analysts continue to assess the implications of these financial results for Cardlytics Inc. These recent developments are crucial for stakeholders monitoring the company’s financial health. The earnings report reflects the company’s current challenges and its ability to meet market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.